Actively Recruiting
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure
Led by Hospices Civils de Lyon · Updated on 2026-01-08
250
Participants Needed
14
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In Intensive Care Unit (ICU) patients with acute kidney injury (AKI) and treated with renal replacement therapy (RRT) often present a fluid overload which is associated with morbidity (mechanical ventilation duration increase, kidney recovery decrease) and mortality. Patients' prognostic could be improved by correcting the fluid overload with net ultrafiltration (UFnet) however it may lead to harmful iatrogenic hypovolemia responsible of deleterious ischemic lesions. In usual practice, UF net prescription are variable and there are different international recommendations. Some observational studies suggest that using a UFnet between 1 et 1.75 mL/kg/h in fluid overloaded patient decrease mortality. Fluid overload increases morbidity and mortality, particularly in RRT. Studies without RRT argue for an efficacy of management by decreasing the fluid overload .Cohort studies suggest to use a moderate UFnet instead of a low UFnet. Some data from studies on early versus late RRT that relate the fluid balance or correct the fluid overload during the early strategy argue for a beneficial effect of an early deresuscitation strategy Consequently, the impact of a moderate UFnet (to decrease the fluid overload) compared to a low UFnet (to stabilize the fluid overload) in a randomized interventional study could be assessed. The study hypothesis is that : an early fluid overload deresuscitation protocol with a high UFnet (2 ml/kg/h) targeting both the negativation of cumulated fluid balance to reach a dry weight and the maintenance of tissue perfusion. Compared to fluid overload deresuscitation protocol with a low UFnet (between 0 and 1 ml/kg/h) to reach a stabilization of cumulated fluid balance without monitoring the tissue perfusion. could improve overall, renal, hemodynamic and respiratory prognosis in fluid overloaded patients with renal replacement therapy in ICU
CONDITIONS
Official Title
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Acute kidney injury treated with continuous renal replacement therapy in ICU for less than 7 days
- At least one additional organ failure during ICU stay (mechanical ventilation, oxygen therapy, fluid resuscitation over 1000 ml, or vasopressor use over 12 hours)
- Weight loss less than 3% since starting net ultrafiltration or cumulative net ultrafiltration less than 2000 ml before inclusion
- Norepinephrine dose less than 0.5 micrograms per kilogram per minute
- No hypoperfusion signs defined by at least two of the following: capillary refill time over 3 seconds at the finger, marbling score over 2, lactate over 2 mmol/L, or central venous oxygen saturation below 60%
- Fluid overload defined as more than 5% increase from baseline weight or obvious edema over 1 cm depth in lumbar or flank areas
You will not qualify if you...
- Chronic renal failure requiring hemodialysis before ICU admission
- Mechanical circulatory support such as ECMO or LVAD
- Pregnant, breastfeeding, or women of childbearing age
- Stroke with central neurological symptoms and compatible brain imaging within the past 30 days
- Intestinal ischemia within the past 7 days without surgery
- Current participation in another interventional study or within exclusion period
- Under guardianship, curatorship, or legal protection
- Lack of signed informed consent by patient or relative
- Not affiliated with a social security or similar scheme
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 14 locations
1
Centre Hospitalier d'Ajaccio
Ajaccio, France, 20090
Not Yet Recruiting
2
CHU Amiens-Picardie
Amiens, France, 80480
Not Yet Recruiting
3
Service d'Anesthesie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon
Bron, France, 69500
Actively Recruiting
4
CHU Caen Normandie
Caen, France, 14033
Not Yet Recruiting
5
Service de Réanimation, CHU de Dijon
Dijon, France, 21000
Actively Recruiting
6
GHP Saint Joseph Marie Lannelongue
Le Plessis-Robinson, France, 92350
Not Yet Recruiting
7
CHU Lille - Hôpital Roger Salengro
Lille, France, 59037
Not Yet Recruiting
8
Hôpital Edouard Herriot, Groupement Hospitalier Centre
Lyon, France, 69003
Actively Recruiting
9
Hôpital de la Croix Rousse
Lyon, France, 69004
Not Yet Recruiting
10
Hôpital de la Croix Rousse
Lyon, France, 69004
Actively Recruiting
11
Service de Réanimation, Clinique de la Sauvegarde
Lyon, France, 69009
Actively Recruiting
12
Hôpital Edouard Herriot
Lyon, France, 69437
Not Yet Recruiting
13
Département d'anesthésie réanimation Hôpital Européen Georges Pompidou
Paris, France, 75015
Actively Recruiting
14
Hôpitaux de Bradois - CHRU Nancy
Vandœuvre-lès-Nancy, France, 54511
Not Yet Recruiting
Research Team
M
Matthias JACQUET LAGREZE, MD PhD
CONTACT
J
Julia CANTERINI, project manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here